Jane Street
PMVP icon

Jane Street’s PMV Pharmaceuticals PMVP Stock Holding History

Jane Street’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-81,600
Closed -$1.16M – 10273
2022
Q2 		$1.16M Buy
81,600
+50,400
+162% +$734K ﹤0.01% 5206
2022
Q1 		$650K Buy
+31,200
New +$550K ﹤0.01% 6995
2021
Q3 		– Sell
-42,000
Closed -$1.44M – 10545
2021
Q2 		$1.44M Buy
+42,000
New +$1.4M ﹤0.01% 5025

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jane Street's PMVP Position: Q1 2026 in Review

Jane Street reduced its PMV Pharmaceuticals (PMVP) stake by 75% in Q1 2026, selling an estimated $476K and leaving 124,014 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #10368.

Jane Street first reported a position in PMVP in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.12M in Q1 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Jane Street held 124,014 shares of PMV Pharmaceuticals worth $154K as of Q1 2026.
  • Jane Street sold 374,627 PMV Pharmaceuticals shares in Q1 2026, an estimated $476K.
  • PMV Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10368 holding.
  • Jane Street first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 14 quarters since.
  • Jane Street's PMV Pharmaceuticals position peaked at $1.12M in Q1 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.